NCT06399263View on ClinicalTrials.gov

Study of Psilocybin for Anorexia in Young Adults

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions
Anorexia Nervosa
Interventions
DRUG

Psilocybin

The psilocybin will include two dose administration sessions, first a 20mg administration, and second an administration of up to 30mg.

BEHAVIORAL

Preparation and Integration Sessions

The psilocybin therapy will include three preparatory sessions, two dose A integration sessions, and four final integration sessions.

Trial Locations (2)

94107

NOT_YET_RECRUITING

University of California, San Francisco, San Francisco

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

Marissa Raymond-Flesch, MD, MPH

OTHER